Answers are grounded in this paper and cite their sources.
Nonthermal atmospheric plasma (NTAP)(also known as cold atmospheric plasma [CAP]) is a rapidly emerging technology showing promising treatment results for a wide variety of dermatologic conditions. Research on NTAP for the treatment of pediatric dermatologic conditions is limited. We conducted a systematic review to elucidate reported applications of NTAP for skin conditions in children. Overall, NTAP offers a promising safety profile and painless treatment option that has the potential to deliver similar efficacy to many standard therapies in pediatric dermatology.
No takes yet. Share an insight, caveat, or question.
M. Green (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: